These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9060910)
1. Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys. Hermsmeyer K; Miyagawa K; Kelley ST; Rösch J; Hall AS; Axthelm MK; Greenberg B J Am Coll Cardiol; 1997 Mar; 29(3):671-80. PubMed ID: 9060910 [TBL] [Abstract][Full Text] [Related]
2. Ca2+ release mechanism of primate drug-induced coronary vasospasm. Miyagawa K; Vidgoff J; Hermsmeyer K Am J Physiol; 1997 Jun; 272(6 Pt 2):H2645-54. PubMed ID: 9227542 [TBL] [Abstract][Full Text] [Related]
3. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. Minshall RD; Miyagawa K; Chadwick CC; Novy MJ; Hermsmeyer K FASEB J; 1998 Oct; 12(13):1419-29. PubMed ID: 9761786 [TBL] [Abstract][Full Text] [Related]
4. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Kemp BK; Cocks TM Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247 [TBL] [Abstract][Full Text] [Related]
5. Platelet-induced vasomotion of isolated canine coronary artery in the presence of halothane or isoflurane. Blaise GA; Parent M; Laurin S; Omri A; Reader TA; Moutquin JM J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):175-81. PubMed ID: 8204810 [TBL] [Abstract][Full Text] [Related]
6. The vasoactive effect of serotonin on canine coronary arteries after ischemia and reperfusion. Sheridan FM Coron Artery Dis; 1994 Jun; 5(6):481-6. PubMed ID: 7952406 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine. Stork AP; Cocks TM Br J Pharmacol; 1994 Dec; 113(4):1093-8. PubMed ID: 7889259 [TBL] [Abstract][Full Text] [Related]
8. Progesterone regulation of vascular thromboxane A(2) receptors in rhesus monkeys. Minshall RD; Pavcnik D; Halushka PV; Hermsmeyer K Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1498-507. PubMed ID: 11557538 [TBL] [Abstract][Full Text] [Related]
9. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane. Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732 [TBL] [Abstract][Full Text] [Related]
10. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Cocks TM; Kemp BK; Pruneau D; Angus JA Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898 [TBL] [Abstract][Full Text] [Related]
17. Effect of hypoxia on contraction and 45Ca2+ uptake induced by the thromboxane mimetic U46619 in sheep coronary artery. Dalen T; Vestereng M; Wadsworth R; Kane K Eur J Pharmacol; 1994 Aug; 270(4):313-9. PubMed ID: 7805780 [TBL] [Abstract][Full Text] [Related]
18. Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery. Zhang CL; de la Lande IS; Horowitz JD Clin Exp Pharmacol Physiol; 1995 May; 22(5):324-9. PubMed ID: 7554422 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms causing coronary microvascular dysfunction following crystalloid cardioplegia and reperfusion. Sellke FW; Friedman M; Dai HB; Shafique T; Schoen FJ; Weintraub RM; Johnson RG Cardiovasc Res; 1993 Nov; 27(11):1925-32. PubMed ID: 8287398 [TBL] [Abstract][Full Text] [Related]